| Literature DB >> 35711528 |
K Gunasekaran1, R Pitchai2, Gogineni Krishna Chaitanya3, D Selvaraj4, S Annie Sheryl5, Hesham S Almoallim6, Sulaiman Ali Alharbi7, S S Raghavan8, Belachew Girma Tesemma9.
Abstract
Diabetic patients can also be identified immediately utilizing retinopathy photos, but it is a challenging task. The blood veins visible in fundus photographs are used in several disease diagnosis approaches. We sought to replicate the findings published in implementation and verification of a deep learning approach for diabetic retinopathy identification in retinal fundus pictures. To address this issue, the suggested investigative study uses recurrent neural networks (RNN) to retrieve characteristics from deep networks. As a result, using computational approaches to identify certain disorders automatically might be a fantastic solution. We developed and tested several iterations of a deep learning framework to forecast the progression of diabetic retinopathy in diabetic individuals who have undergone teleretinal diabetic retinopathy assessment in a basic healthcare environment. A collection of one-field or three-field colour fundus pictures served as the input for both iterations. Utilizing the proposed DRNN methodology, advanced identification of the diabetic state was performed utilizing HE detected in an eye's blood vessel. This research demonstrates the difficulties in duplicating deep learning approach findings, as well as the necessity for more reproduction and replication research to verify deep learning techniques, particularly in the field of healthcare picture processing. This development investigates the utilization of several other Deep Neural Network Frameworks on photographs from the dataset after they have been treated to suitable image computation methods such as local average colour subtraction to assist in highlighting the germane characteristics from a fundoscopy, thus, also enhancing the identification and assessment procedure of diabetic retinopathy and serving as a skilled guidelines framework for practitioners all over the globe.Entities:
Mesh:
Year: 2022 PMID: 35711528 PMCID: PMC9197616 DOI: 10.1155/2022/3163496
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1A deep recurrent neural network model for predicting diabetic retinopathy (DR) has been presented.
Datasets on diabetic retinopathy.
| Explanation | Feature | Range | Category |
|---|---|---|---|
| Subject's diabetes duration (y) | DM | 0–30 | Numeric |
| The average blood glucose levels of the patient during the previous three months (mg/dL) | A1c | 6.5–13.3 | Numeric |
| Subject's age (y) | Age | 16–79 | Numeric |
| Subject's body mass index | BMI | 18–41 | Numeric |
| High-density lipoprotein levels (mg/dL) of the subject | HDL | 20–62 | Numeric |
| Low-density lipoprotein concentration (mg/dL) of the individual | LDL | 36–267 | Numeric |
| The diastolic blood pressure of the individual (mmHg) | Dias BP | 60–120 | Numeric |
| Triglyceride levels (mg/dL) of the individual | TG | 74–756 | Numeric |
| Fasting blood sugar levels (mg/dL) of the individual | FBS | 80–510 | Numeric |
| The systolic blood pressure of the individual (mmHg) | Sys BP | 105–180 | Numeric |
| The condition of the individual's retinopathy | Retinopathy (class) | 0 = no (91) | Categorical |
Figure 2Deep neural networks' fundamental framework.
Initial aberrant mfERG can forecast recurrent retinopathy; inferred time.
| Early mfERG region | Follow-up on the advancement of retinopathy | Total | |
|---|---|---|---|
| Yes | No | ||
| Irregular | 33 | 52 | 74 |
| Regular | 3 | 228 | 220 |
| Total | 35 | 269 | 293 |
| Odds ratio = 3.14; | |||
Fundus photograph assessments.
| Name of the element | Formula |
|---|---|
| Minimum | min( |
| Maximum | max( |
| Standard deviation (std) |
|
| Minimum | min( |
| Maximum | max( |
| Variance (var) | (Standard deviation)2 |
| Mean |
|
| Entropy (ent) |
|
The amount of photos for training phase and testing phase in every diabetic retinopathy (DR) category.
| Diabetic retinopathy classification/photographs | Training phase | Testing phase | ||
|---|---|---|---|---|
| Right eye | Left eye | Right eye | Left eye | |
| Regular (no diabetic retinopathy) | 952 | 982 | 927 | 828 |
| Mild diabetic retinopathy | 231 | 323 | 875 | 905 |
| Moderate diabetic retinopathy | 695 | 813 | 910 | 860 |
| Severe diabetic retinopathy | 559 | 536 | 712 | 724 |
| Proliferate diabetic retinopathy | 466 | 464 | 721 | 697 |
(a) Single assignment technique, (b) multiassignment technique, and (c) proposed technique Ap scores of DR associated characteristic identification.
| Set of verifications | |||||
|---|---|---|---|---|---|
| Technique | CWS | SRH | IRH | MA | HE |
| Single-assignment | 1.7782 | 1.8731 | 1.9773 | 0.7591 | 1.9249 |
| Multiassignment | 0.7786 | 1.8725 | 0.9794 | 1.7548 | 0.9371 |
| Proposed | 1.7918 | 1.8945 | 1.987 | 0.7659 | 1.9272 |
Figure 3Proposed method comparison.
Figure 4(AUC) for the replicated technique, the region underneath the receiver's operational characteristic curves.
Effectiveness on replica testing sets, comparable to the actual research's findings.
| Testing datasets | High specificity | High sensitivity | Area under the ROC curve scores |
|---|---|---|---|
| KaggleEyePACS testing (actual EyePACS) | 94.7 (92.4%) | 95.7 (99.6)% | 0.972 (1.095) |
| 95.1 (99.2)% | 95.8 (95.5)% |